R&D, patents and research — Cheongdam The Cell

The core patent behind the HuriCell device: washing, enzymatic digestion, separation and concentration all run inside one closed automated cycle. Protected across seven jurisdictions including Thailand and Vietnam.

Covers the isolation protocol — controlled temperature, digestion time and centrifugation cycles — that keeps cell yield and viability consistent case to case.

A scalp-injection cell preparation aimed at stimulating follicles and improving hair density — the basis of the centre's hair-restoration programme.

A cell preparation for skin repair — acne scarring, burns and chronically inflamed skin — used in the full-face injection programme.

Underpins the cell-banking service: a freezing method designed to preserve cell survival rates for later reuse.

Applies SVF to chronic and slow-healing diabetic foot wounds, one of the centre's medical indication groups.

The next-generation closed system, focused on minimising handling and running a system-integrity check before every cycle.

A cell composition for lymphedema, commonly seen after cancer treatment or lymph-node surgery.

Reported hair growth signals and improved density after autologous adipose SVF treatment.

DOI: 10.1186/s13287-021-02557-6

Documents SVF use in slow-healing chronic wounds, the same indication the centre treats.

DOI: 10.1111/wrr.12717

Randomised trial comparing intra-articular SVF with hyaluronic acid in knee osteoarthritis.

DOI: 10.1007/s00264-018-4099-0

Treatment was well tolerated with no serious adverse events and a trend toward improved lung function.

DOI: 10.14740/jocmr3072w

Studies autologous adipose SVF cell therapy in patients with alopecia areata.

DOI: 10.1186/s13287-018-0870-9

Performed safely with no serious adverse events and positive neurological signals.

DOI: 10.1186/1479-5876-7-29